Searched for
MALARIA VACCINE INDIA
Ebola virus in India? Here's the latest update on the Bengaluru scare, symptoms and precautions explainedEbola virus in Bangalore: A woman returning from Uganda was quarantined in Bengaluru with Ebola-like symptoms. Her tests have come back neg...- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Oxford University strikes new malaria vaccine pact with Serum Institute of IndiaOxford University and Serum Institute of India are collaborating on a new malaria vaccine, R78C. This partnership aims to create a more eff...
- Expert panel has recommended that India doesn't fall within criteria for adopting malaria vaccines: GovtAn expert panel suggests India need not adopt malaria vaccines. These vaccines are for areas with moderate to high transmission. They are a...
- Development of indigenous multi-stage Malaria vaccine 'AdFalciVax' is underwayIndia is developing a new malaria vaccine. The Indian Council of Medical Research is leading the effort. The vaccine is called AdFalciVax. ...
- Bharat Biotech, GSK to halve price of malaria vaccine by 2028Drugmakers Bharat Biotech and GSK will reduce the price of their malaria vaccine, Mosquirix, to $5 per dose by 2028, more than halving the ...
- Serum Institute of India's new 'high efficacy' malaria vaccine rolls out in AfricaThe Serum Institute of India (SII) and Oxford University have launched a "high efficacy" malaria vaccine, R21/Matrix-M, in Cote d'Ivoire. A...
- SII commences shipments of malaria vaccine 'R21/Matrix-M' to AfricaSerum Institute of India (SII) commenced exporting the 'R21/Matrix-M' malaria vaccine to Africa in collaboration with the University of Oxf...
- WHO expert panel recommends Oxford University-Serum Institute's anti-malaria vaccineThe R21/Matrix-M™ malaria vaccine is an easily deployable vaccine that can be manufactured at mass scale and modest cost, enabling as many ...
- Oxford-Serum malaria vaccine wins WHO's recommendationThe R21/Matrix-M malaria vaccine is an easily deployable vaccine that can be manufactured at mass scale at a modest cost, enabling as many ...
- Malaria vaccine by Oxford & Serum Institute of India gets WHO recommendationThe University of Oxford and Serum Institute of India (SII) have developed a malaria vaccine, which has been recommended for use by the Wor...
- UN authorises 2nd malaria vaccine, developed by Oxford University with help from Serum Institute of IndiaResearch suggests it is more than 75% effective and that protection is maintained for at least another year with a booster. Tedros said the...
- Oxford University, Serum Institute of India tie-up delivers 'high efficacy' malaria vaccineThe R21/Matrix-M vaccine, leveraging Novavax's adjuvant technology, has been approved for use in children aged 5 to 36 months - the age gro...
- Oxford, Serum Institute of India: New Anti-Malaria vaccine trial over, authorization next yearThe phase 3 trial of the R21 malaria vaccine, also known as Matrix-M and developed by the Jenner Institute at the University of Oxford, has...
- DCGI allows Serum Institute to export malaria vaccine to UKIndia's drug regulator has allowed the export of the first produced-in-India vaccine against malaria, developed by scientists at the Univer...
- India should set up its malaria vax manufacturing units in AfricaBharat Biotech will be manufacturing the recently approved vaccine Mosquirix for combating malaria. Setting up production units in Africa w...
- Bharat Biotech to produce world's 1st malaria vaccine approved by WHOEarlier, WHO endorsed the world's first malaria vaccine and said it should be given to children across Africa in the hope that it will spur...
- 'Landmark' advance as malaria vaccine first to hit WHO goalIn a clinical trial in Burkina Faso, the Matrix-M vaccine -- developed by the University of Oxford's Jenner Institute -- was found to be 77...
- Tata Institute of Fundamental Research publishes paper on breakthrough in malaria vaccineThe need for a vaccine to control malaria has become important because of emerging resistance to existing anti-malarial pills.
- Cadila Pharmaceuticals and Novavax to develop malaria vaccine using virus like particle technologyCadila Pharma and Novavax to develop new malaria vaccine using VLP technology. ICGEB also to partner them in the project.
Load More
